ACER THERAPEUTICS INC has a total of 13 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are CHEN ANDREW XIAN, FIRSTSTRING RES INC and SHENYANG SINQI PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Schelling D Christopher | 8 |
#2 | Appel Leah E | 8 |
#3 | Shockey Joshua R | 7 |
#4 | Leah E Appel | 2 |
#5 | D Christopher Schelling | 2 |
#6 | Tchernychev Boris | 2 |
#7 | Joshua R Shockey | 2 |
#8 | Mcmurry Thomas J | 1 |
#9 | Shockey Joshoua R | 1 |
#10 | Looby Richard J | 1 |
Publication | Filing date | Title |
---|---|---|
CA3017573A1 | Palatable compositions including sodium phenylbutyrate and uses thereof | |
EP2566494A2 | Cxcr4 receptor compounds |